Sevoflurane

七氟烷

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSevoflurane
Drug Alias NameSevofluranum七氟醚七氟异丙甲醚SevofraneSevorane +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDrug intoxicationsOpioid-Related DisordersAlcohol-Related Disorders +[14] 
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryJapan
Original Approved Date1990/01/01
Country/TerritoryCanadaUnited StatesSweden +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of ZurichNational Institute Of General Medical SciencesAbbvie Inc +[4] 
Inactive CompaniesF Javier BeldaLawson Health Research InstituteThe University Of Chicago +[5] 
Active IndicationsPainAmnesiaRespiratory Distress Syndrome, Adult +[6] 
Inactive IndicationsDrug intoxicationsOpioid-Related DisordersAlcohol-Related Disorders +[8] 

Other Information

ATC CodeN01AB08
Related LinksWikipediaDrugBankKEGG